Tuesday, 25 July 2017

Transasia Bio-Medicals acquires Calbiotech Group of US

27 April 2017 | News

Transasia Bio-Medicals Ltd. has recently acquired Calbiotech Group of Companies in the US through its German subsidiary Erba Mannheim.

Strengthening its foray into immunoassay, Transasia Bio-Medicals Ltd., India’s leading in-vitro diagnostic company, has recently acquired Calbiotech Group of Companies in the US through its German subsidiary Erba Mannheim.

With this new addition, the Transasia-Erba Group is all set to strengthen its foray in ELISA and CLIA assays for human and animal research, including specific assays for autoimmune disorders, cancer and infectious diseases.

The California-based Calbiotech Group is a global leader in immunoassay development and manufacturing. Whereas, Transasia Bio-Medicals Ltd offers a comprehensive product portfolio spanning all specialties of diagnostics including biochemistry, hematology, immunoassay and blood banking, urinalysis, diabetes, critical care, coagulation, microbiology and molecular diagnostics.

 Along with its subsidiaries in Germany, France, Czech Republic, Russia, Turkey, the UK and USA, Transasia now reaches out to millions in over 104 countries.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Is digitalisation a global challenge for Indian pharma companies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls